Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma

By Hoar F.J.   Chaudhri S.   Wadley M.S.   Stonelake P.S.  

European Journal of Cancer, Vol. 39, Iss. 12, 2003-08 ,pp. : 1698-1703

Elsevier

Access to resources Recommend Favorite

p53 protein expression in ductal carcinoma in situ (DCIS) of the breast

By Rajan P.B.  

Breast Cancer Research and Treatment, Vol. 42, Iss. 3, 1997-02 ,pp. : 283-290

Springer Publishing Company

Access to resources Recommend Favorite

C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer

By Sjostrom J.   Collan J.   von Boguslawski K.   Franssila K.   Bengtsson N.-O.   Mjaaland I.   Malmstrom P.   Ostenstad B.   Wist E.   Valvere V.   Bergh J.   Skiold-Petterson D.   Saksela E.   Blomqvist C.  

European Journal of Cancer, Vol. 38, Iss. 4, 2002-03 ,pp. : 535-542

Elsevier

Access to resources Recommend Favorite

c-erbB-2 Expression and Benefit From Adjuvant Chemotherapy and Radiotherapy of Breast Cancer

By Stal O.   Sullivan S.   Wingren S.   Skoog L.   Rutqvist L.E.   Carstensen J.M.   Nordenskjold B.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2185-2190

Elsevier

Access to resources Recommend Favorite

Differential C-erbB-2 and VEGF expression following BCG immunotherapy in superficial papillary transitional cell carcinoma of the bladder

By Morgan B.E.   Salup R.   Morgan M.B.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 2, 2002-03 ,pp. : 67-72

Elsevier

Access to resources Recommend Favorite